| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 23 | 2020 | 482 | 5.410 |
Why?
|
| Breast Neoplasms | 49 | 2024 | 2486 | 4.380 |
Why?
|
| Xenograft Model Antitumor Assays | 26 | 2024 | 876 | 2.250 |
Why?
|
| Neoplastic Stem Cells | 11 | 2018 | 294 | 2.150 |
Why?
|
| Breast | 10 | 2020 | 214 | 2.060 |
Why?
|
| Hedgehog Proteins | 14 | 2020 | 192 | 1.900 |
Why?
|
| Epithelial Cells | 11 | 2020 | 900 | 1.760 |
Why?
|
| Triple Negative Breast Neoplasms | 13 | 2022 | 224 | 1.610 |
Why?
|
| Signal Transduction | 31 | 2022 | 4495 | 1.610 |
Why?
|
| Models, Biological | 13 | 2021 | 1442 | 1.410 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2015 | 280 | 1.300 |
Why?
|
| Morphogenesis | 5 | 2017 | 212 | 1.250 |
Why?
|
| Cell Proliferation | 22 | 2021 | 2307 | 1.170 |
Why?
|
| Drug Resistance, Neoplasm | 15 | 2021 | 714 | 1.120 |
Why?
|
| Animals | 83 | 2024 | 33723 | 1.110 |
Why?
|
| Mice | 65 | 2022 | 17487 | 1.060 |
Why?
|
| Patched-1 Receptor | 7 | 2019 | 33 | 0.990 |
Why?
|
| Cell Line, Tumor | 28 | 2022 | 3277 | 0.960 |
Why?
|
| Epithelium | 7 | 2022 | 366 | 0.960 |
Why?
|
| Mammary Glands, Human | 6 | 2013 | 79 | 0.870 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 216 | 0.860 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2018 | 617 | 0.850 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 1677 | 0.850 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 543 | 0.850 |
Why?
|
| Heterografts | 9 | 2024 | 179 | 0.790 |
Why?
|
| Receptors, Cell Surface | 7 | 2018 | 469 | 0.730 |
Why?
|
| Female | 78 | 2024 | 65444 | 0.720 |
Why?
|
| Lactation | 3 | 2020 | 187 | 0.720 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 669 | 0.700 |
Why?
|
| Milk Proteins | 1 | 2020 | 91 | 0.690 |
Why?
|
| Nanocapsules | 2 | 2017 | 7 | 0.670 |
Why?
|
| Nanotubes, Carbon | 2 | 2017 | 19 | 0.670 |
Why?
|
| Transcription Factors | 6 | 2020 | 2585 | 0.660 |
Why?
|
| Stem Cells | 4 | 2018 | 700 | 0.640 |
Why?
|
| Mice, SCID | 14 | 2022 | 571 | 0.640 |
Why?
|
| Mammary Neoplasms, Animal | 5 | 2018 | 137 | 0.620 |
Why?
|
| Paracrine Communication | 3 | 2017 | 71 | 0.600 |
Why?
|
| Cisplatin | 2 | 2017 | 242 | 0.600 |
Why?
|
| Mice, Transgenic | 11 | 2016 | 2390 | 0.570 |
Why?
|
| Neoplasms, Experimental | 2 | 2017 | 211 | 0.550 |
Why?
|
| Cell Size | 2 | 2016 | 81 | 0.550 |
Why?
|
| Smoothened Receptor | 6 | 2017 | 28 | 0.530 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 6 | 0.510 |
Why?
|
| Cell Differentiation | 9 | 2020 | 1907 | 0.500 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 353 | 0.490 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 4269 | 0.480 |
Why?
|
| Claudins | 1 | 2014 | 29 | 0.480 |
Why?
|
| Humans | 80 | 2024 | 123157 | 0.470 |
Why?
|
| Collagen | 3 | 2012 | 313 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2022 | 1870 | 0.460 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 2047 | 0.450 |
Why?
|
| Cell Separation | 2 | 2019 | 232 | 0.440 |
Why?
|
| Laminin | 2 | 2012 | 59 | 0.420 |
Why?
|
| Proteoglycans | 2 | 2012 | 93 | 0.410 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 53 | 0.390 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 123 | 0.380 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 119 | 0.370 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2020 | 215 | 0.370 |
Why?
|
| Integrases | 3 | 2019 | 161 | 0.360 |
Why?
|
| Apoptosis | 12 | 2021 | 1780 | 0.360 |
Why?
|
| Mice, Nude | 10 | 2021 | 692 | 0.350 |
Why?
|
| Veratrum Alkaloids | 2 | 2017 | 10 | 0.350 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 40 | 0.330 |
Why?
|
| Trans-Activators | 3 | 2004 | 809 | 0.330 |
Why?
|
| Genes, Homeobox | 2 | 2000 | 70 | 0.330 |
Why?
|
| Mice, Knockout | 10 | 2020 | 3715 | 0.330 |
Why?
|
| Neoplasms | 7 | 2021 | 2766 | 0.320 |
Why?
|
| Mammary Tumor Virus, Mouse | 4 | 2018 | 106 | 0.320 |
Why?
|
| Taxoids | 5 | 2013 | 68 | 0.310 |
Why?
|
| Neoplasm Metastasis | 7 | 2021 | 649 | 0.300 |
Why?
|
| Myeloid-Derived Suppressor Cells | 2 | 2020 | 48 | 0.300 |
Why?
|
| Progesterone | 5 | 2017 | 624 | 0.290 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2007 | 5 | 0.280 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 13 | 0.280 |
Why?
|
| Mutation | 10 | 2021 | 5773 | 0.280 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2016 | 25 | 0.280 |
Why?
|
| Ascomycota | 2 | 1997 | 25 | 0.280 |
Why?
|
| Mice, Inbred BALB C | 5 | 2017 | 1002 | 0.270 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2021 | 253 | 0.270 |
Why?
|
| Everolimus | 1 | 2016 | 46 | 0.270 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2019 | 69 | 0.270 |
Why?
|
| Research Design | 2 | 2009 | 687 | 0.270 |
Why?
|
| Patched Receptors | 5 | 2010 | 26 | 0.260 |
Why?
|
| Fungal Proteins | 2 | 1997 | 134 | 0.260 |
Why?
|
| Precancerous Conditions | 3 | 2018 | 287 | 0.260 |
Why?
|
| Mice, Inbred NOD | 6 | 2018 | 285 | 0.250 |
Why?
|
| Spheroids, Cellular | 3 | 2014 | 58 | 0.250 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 1580 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2021 | 186 | 0.240 |
Why?
|
| Adipose Tissue | 2 | 2022 | 465 | 0.240 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 992 | 0.240 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2014 | 243 | 0.230 |
Why?
|
| Estrogen Receptor alpha | 3 | 2021 | 450 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 340 | 0.230 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 182 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 240 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2009 | 1528 | 0.220 |
Why?
|
| CD24 Antigen | 3 | 2013 | 29 | 0.210 |
Why?
|
| Neoplasm Transplantation | 7 | 2019 | 368 | 0.210 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 1432 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2011 | 996 | 0.210 |
Why?
|
| Genes, Reporter | 3 | 2014 | 384 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 197 | 0.210 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 428 | 0.210 |
Why?
|
| Precision Medicine | 3 | 2022 | 313 | 0.210 |
Why?
|
| Wnt Signaling Pathway | 2 | 2014 | 195 | 0.200 |
Why?
|
| Drosophila Proteins | 2 | 2016 | 707 | 0.200 |
Why?
|
| Estrogens | 3 | 2017 | 507 | 0.200 |
Why?
|
| Heterozygote | 4 | 2011 | 672 | 0.200 |
Why?
|
| Ribonuclease III | 2 | 2013 | 87 | 0.200 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 118 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2020 | 810 | 0.190 |
Why?
|
| RNA Helicases | 1 | 2022 | 63 | 0.190 |
Why?
|
| Transcriptome | 4 | 2021 | 908 | 0.190 |
Why?
|
| Stem Cell Niche | 2 | 2012 | 55 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 9 | 0.190 |
Why?
|
| Pregnancy | 9 | 2020 | 7137 | 0.180 |
Why?
|
| Neuropilin-2 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Receptors, Estrogen | 5 | 2012 | 789 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 98 | 0.180 |
Why?
|
| Gene Expression Profiling | 8 | 2015 | 1680 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2021 | 53 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 39 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 1293 | 0.180 |
Why?
|
| Sexual Maturation | 2 | 2019 | 48 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 1115 | 0.170 |
Why?
|
| Transplants | 1 | 2020 | 36 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2020 | 55 | 0.170 |
Why?
|
| Glycolysis | 1 | 2020 | 141 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 183 | 0.170 |
Why?
|
| Flow Cytometry | 3 | 2013 | 803 | 0.170 |
Why?
|
| ras Proteins | 1 | 2020 | 136 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 190 | 0.170 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 22 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 172 | 0.160 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 76 | 0.160 |
Why?
|
| Insect Proteins | 1 | 1999 | 98 | 0.160 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 222 | 0.160 |
Why?
|
| Peptides | 3 | 2018 | 796 | 0.160 |
Why?
|
| Carboplatin | 1 | 2019 | 75 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 1062 | 0.160 |
Why?
|
| Pituitary Gland | 1 | 2019 | 84 | 0.160 |
Why?
|
| Organoids | 1 | 2022 | 276 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 93 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 1999 | 137 | 0.160 |
Why?
|
| Time Factors | 6 | 2013 | 6204 | 0.160 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2018 | 9 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 74 | 0.160 |
Why?
|
| Tamoxifen | 2 | 2011 | 363 | 0.160 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2010 | 91 | 0.160 |
Why?
|
| Proteomics | 2 | 2020 | 479 | 0.150 |
Why?
|
| Base Sequence | 5 | 2011 | 3093 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4346 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 19 | 0.150 |
Why?
|
| Cell Plasticity | 1 | 2018 | 32 | 0.150 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 326 | 0.150 |
Why?
|
| DNA Repair | 2 | 2013 | 581 | 0.150 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 28 | 0.150 |
Why?
|
| Mesoderm | 2 | 2009 | 114 | 0.150 |
Why?
|
| Response Elements | 1 | 2018 | 97 | 0.150 |
Why?
|
| Phenotype | 4 | 2013 | 4221 | 0.150 |
Why?
|
| Lentivirus | 2 | 2014 | 84 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 37 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2018 | 83 | 0.140 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 1997 | 1 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 1230 | 0.140 |
Why?
|
| Cell Shape | 1 | 2017 | 61 | 0.140 |
Why?
|
| Cell Movement | 3 | 2020 | 831 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 269 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2017 | 98 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2018 | 393 | 0.140 |
Why?
|
| Receptor, ErbB-2 | 5 | 2013 | 496 | 0.130 |
Why?
|
| Homozygote | 3 | 2011 | 533 | 0.130 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 157 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 394 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 268 | 0.130 |
Why?
|
| Hyaluronan Receptors | 3 | 2013 | 66 | 0.130 |
Why?
|
| Body Patterning | 1 | 2016 | 122 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2016 | 612 | 0.130 |
Why?
|
| Hypogonadism | 1 | 2019 | 249 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 211 | 0.130 |
Why?
|
| Biological Evolution | 1 | 1996 | 221 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2016 | 90 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 939 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2016 | 98 | 0.120 |
Why?
|
| Carcinogenesis | 2 | 2016 | 327 | 0.120 |
Why?
|
| Wnt1 Protein | 2 | 2018 | 71 | 0.120 |
Why?
|
| Eye | 1 | 2016 | 226 | 0.120 |
Why?
|
| Fluorescence | 1 | 2014 | 93 | 0.120 |
Why?
|
| Tumor Burden | 2 | 2012 | 229 | 0.120 |
Why?
|
| Dioxolanes | 1 | 2014 | 11 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 142 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2015 | 208 | 0.120 |
Why?
|
| Drug Repositioning | 1 | 2014 | 22 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 576 | 0.110 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 2698 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 136 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 473 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 477 | 0.110 |
Why?
|
| Kinetics | 1 | 2016 | 1313 | 0.110 |
Why?
|
| Separase | 1 | 2014 | 29 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 104 | 0.110 |
Why?
|
| Drug Combinations | 2 | 2012 | 271 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2016 | 338 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 353 | 0.110 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 238 | 0.110 |
Why?
|
| Cytokines | 1 | 1999 | 1283 | 0.110 |
Why?
|
| Down-Regulation | 3 | 2011 | 696 | 0.110 |
Why?
|
| Molecular Sequence Data | 6 | 2010 | 3871 | 0.110 |
Why?
|
| Propionates | 1 | 2013 | 30 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2011 | 473 | 0.110 |
Why?
|
| Benzene Derivatives | 1 | 2013 | 19 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3047 | 0.110 |
Why?
|
| Integrin beta1 | 1 | 2013 | 54 | 0.110 |
Why?
|
| Sulfones | 1 | 2013 | 67 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2019 | 989 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2017 | 656 | 0.100 |
Why?
|
| Estradiol | 2 | 2012 | 534 | 0.100 |
Why?
|
| Receptors, Notch | 2 | 2013 | 202 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 330 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 62 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2018 | 1611 | 0.100 |
Why?
|
| Cadherins | 2 | 2010 | 164 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 3 | 2010 | 321 | 0.100 |
Why?
|
| ErbB Receptors | 2 | 2010 | 284 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2848 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2013 | 2815 | 0.100 |
Why?
|
| Zinc Finger Protein Gli2 | 2 | 2001 | 12 | 0.100 |
Why?
|
| Biomarkers | 3 | 2021 | 2942 | 0.100 |
Why?
|
| Algorithms | 1 | 2018 | 1595 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 130 | 0.090 |
Why?
|
| Stromal Cells | 2 | 2011 | 294 | 0.090 |
Why?
|
| Computational Biology | 1 | 2016 | 800 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 85 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2011 | 103 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 340 | 0.090 |
Why?
|
| Uterus | 2 | 2019 | 594 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 678 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 29 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2016 | 765 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 766 | 0.090 |
Why?
|
| Prognosis | 5 | 2021 | 4505 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2001 | 110 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2011 | 210 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 187 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 258 | 0.090 |
Why?
|
| Cell Hypoxia | 3 | 2017 | 94 | 0.090 |
Why?
|
| Anthracyclines | 1 | 2010 | 42 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 860 | 0.090 |
Why?
|
| Cell Communication | 1 | 2011 | 165 | 0.090 |
Why?
|
| Neutral Red | 1 | 2009 | 1 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 94 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2021 | 202 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2011 | 214 | 0.080 |
Why?
|
| Graft Survival | 1 | 2012 | 524 | 0.080 |
Why?
|
| Monocytes | 1 | 2012 | 346 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 111 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 194 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 714 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1004 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2018 | 534 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2013 | 1012 | 0.080 |
Why?
|
| Proteins | 2 | 1999 | 1038 | 0.080 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1989 | 23 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 1677 | 0.080 |
Why?
|
| Lectins | 1 | 1989 | 49 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2009 | 183 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 287 | 0.080 |
Why?
|
| Receptors, Progesterone | 5 | 2010 | 865 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 121 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2010 | 165 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2008 | 179 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 260 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 158 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2010 | 303 | 0.080 |
Why?
|
| Mammography | 1 | 2009 | 113 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 1265 | 0.070 |
Why?
|
| Embryo Implantation | 1 | 2010 | 230 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2014 | 935 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 462 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 319 | 0.070 |
Why?
|
| Survival Rate | 3 | 2021 | 1993 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 554 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 352 | 0.070 |
Why?
|
| Macrophages | 1 | 2011 | 603 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 30 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1683 | 0.070 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 254 | 0.070 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2006 | 28 | 0.070 |
Why?
|
| Ki-67 Antigen | 1 | 2007 | 113 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 1338 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 131 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 1999 | 623 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 87 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 455 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 409 | 0.070 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 100 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 1997 | 293 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 809 | 0.060 |
Why?
|
| Transgenes | 1 | 2007 | 334 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 525 | 0.060 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 92 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 572 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 1997 | 269 | 0.060 |
Why?
|
| Protein Array Analysis | 2 | 2018 | 101 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 455 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 354 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 102 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1515 | 0.060 |
Why?
|
| Maximum Tolerated Dose | 2 | 2014 | 157 | 0.050 |
Why?
|
| Genomics | 2 | 2021 | 1477 | 0.050 |
Why?
|
| Cell Survival | 2 | 2018 | 803 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 657 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1217 | 0.050 |
Why?
|
| Transplantation | 1 | 2001 | 28 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2001 | 113 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2011 | 312 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 206 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 63 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2531 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2022 | 171 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 514 | 0.040 |
Why?
|
| Male | 7 | 2021 | 60040 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 228 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 88 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 302 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 1999 | 48 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 289 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2020 | 55 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 21 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2020 | 122 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 223 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 132 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 52 | 0.040 |
Why?
|
| Alagille Syndrome | 1 | 1999 | 46 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 54 | 0.040 |
Why?
|
| Keratins | 1 | 2019 | 56 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 67 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 490 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 1101 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2019 | 90 | 0.040 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 472 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 38 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 286 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 272 | 0.040 |
Why?
|
| Carcinogens | 2 | 2009 | 153 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 471 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 61 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2011 | 637 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 340 | 0.040 |
Why?
|
| Haplotypes | 1 | 1999 | 519 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
| Triazoles | 1 | 2018 | 138 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 893 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2017 | 71 | 0.040 |
Why?
|
| Genes | 1 | 2018 | 444 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 133 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2000 | 369 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2011 | 867 | 0.040 |
Why?
|
| Neurospora crassa | 1 | 1997 | 5 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 35 | 0.040 |
Why?
|
| Pericytes | 1 | 2017 | 23 | 0.040 |
Why?
|
| Reproduction | 1 | 2019 | 243 | 0.040 |
Why?
|
| Testis | 1 | 2019 | 405 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1997 | 54 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2018 | 422 | 0.030 |
Why?
|
| Neurospora | 1 | 1996 | 2 | 0.030 |
Why?
|
| Hypocreales | 1 | 1996 | 2 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1997 | 63 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 78 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1996 | 187 | 0.030 |
Why?
|
| Alleles | 1 | 2001 | 1604 | 0.030 |
Why?
|
| Proteome | 1 | 2018 | 233 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 105 | 0.030 |
Why?
|
| Patients | 1 | 2017 | 121 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 809 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 666 | 0.030 |
Why?
|
| Ovary | 1 | 2019 | 389 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 152 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 2016 | 89 | 0.030 |
Why?
|
| United States | 2 | 2022 | 10629 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 237 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 97 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 276 | 0.030 |
Why?
|
| Pyridines | 1 | 2017 | 224 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2008 | 353 | 0.030 |
Why?
|
| Genotype | 1 | 2001 | 2540 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 172 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 165 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 96 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 552 | 0.030 |
Why?
|
| Clonal Evolution | 1 | 2015 | 38 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 444 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 150 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 511 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 462 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
| Exome | 1 | 2019 | 1041 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 45 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 374 | 0.030 |
Why?
|
| Rhodamines | 1 | 2014 | 22 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 38 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 75 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 664 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 112 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 155 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 386 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2013 | 14 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 528 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 96 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 2013 | 8 | 0.030 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 672 | 0.030 |
Why?
|
| Research | 1 | 2015 | 263 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2013 | 35 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 262 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 288 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 137 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1760 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 348 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 62 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 157 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2013 | 122 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 370 | 0.030 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2011 | 4 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2013 | 161 | 0.020 |
Why?
|
| Platinum | 1 | 2011 | 12 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 399 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2585 | 0.020 |
Why?
|
| Solvents | 1 | 2011 | 42 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 123 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2011 | 98 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 242 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 287 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 738 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 124 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2010 | 67 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 506 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2013 | 420 | 0.020 |
Why?
|
| Epirubicin | 1 | 2010 | 5 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3251 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2010 | 6 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 78 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2013 | 369 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 661 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2010 | 128 | 0.020 |
Why?
|
| Calcinosis | 1 | 2011 | 167 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 269 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 273 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 199 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 198 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 647 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 400 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 312 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 601 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2019 | 12116 | 0.020 |
Why?
|
| Ranidae | 1 | 1989 | 7 | 0.020 |
Why?
|
| Turtles | 1 | 1989 | 8 | 0.020 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 1989 | 6 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1569 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 382 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 56 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 779 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 1213 | 0.020 |
Why?
|
| Decidua | 1 | 2010 | 136 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 60 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 55 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 796 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 878 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 557 | 0.020 |
Why?
|
| Parity | 1 | 2008 | 80 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5046 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 74 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 420 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 389 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 256 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1989 | 229 | 0.020 |
Why?
|
| Cattle | 1 | 1989 | 559 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1991 | 550 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1989 | 568 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 533 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 6373 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 292 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 459 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2007 | 24 | 0.020 |
Why?
|
| Quinazolines | 1 | 2008 | 175 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2007 | 56 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 1068 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2007 | 41 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 2006 | 17 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1989 | 836 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 111 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2007 | 128 | 0.020 |
Why?
|
| Pyridones | 1 | 2007 | 112 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1743 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 1089 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1585 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1796 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 769 | 0.010 |
Why?
|
| Middle Aged | 3 | 2009 | 25966 | 0.010 |
Why?
|
| Adult | 3 | 2009 | 29034 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3631 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 2799 | 0.010 |
Why?
|
| Aged | 2 | 2009 | 19067 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 3329 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10010 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1991 | 37 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1991 | 152 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1991 | 41 | 0.010 |
Why?
|